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ABSTRACT
The Influenza Research Database (IRD) is a U.S. Na-
tional Institute of Allergy and Infectious Diseases
(NIAID)-sponsored Bioinformatics Resource Center
dedicated to providing bioinformatics support for in-
fluenza virus research. IRD facilitates the research
and development of vaccines, diagnostics and ther-
apeutics against influenza virus by providing a com-
prehensive collection of influenza-related data inte-
grated from various sources, a growing suite of anal-
ysis and visualization tools for data mining and hy-
pothesis generation, personal workbench spaces for
data storage and sharing, and active user community
support. Here, we describe the recent improvements
in IRD including the use of cloud and high perfor-
mance computing resources, analysis and visualiza-
tion of user-provided sequence data with associated
metadata, predictions of novel variant proteins, an-
notations of phenotype-associated sequence mark-
ers and their predicted phenotypic effects, hemag-
glutinin (HA) clade classifications, an automated tool
for HA subtype numbering conversion, linkouts to
disease event data and the addition of host factor
and antiviral drug components. All data and tools
are freely available without restriction from the IRD
website at https://www.fludb.org.
INTRODUCTION
Influenza virus is a major global public health threat.
The World Health Organization (WHO) estimates that
approximately 5–10% of adults and 20–30% of children
are infected by influenza annually (1). Of those, 3–5 mil-
lion infected individuals experience severe illness result-
ing in approximately 250 000–500 000 deaths annually.
In order to advance influenza virus research, the Na-
tional Institute of Allergy and Infectious Diseases (NI-
AID) at the US National Institutes of Health (NIH) is sup-
porting the freely available, web-based Influenza Research
Database (IRD) through the Bioinformatics Resource Cen-
ters program (https://www.niaid.nih.gov/labsandresources/
resources/dmid/brc/). The objective of the IRD resource is
to provide a one-stop shop for influenza virus data and
analysis tools to drive new discoveries about influenza virus
transmission, virulence, host range and pathogenesis, and
to develop novel strategies for diagnosis, prevention and
therapeutic intervention.
IRD is comprised of three major components:
i) a comprehensive collection of influenza virus related
data integrated from public archives, data submitters
and IRD in-house curation and annotation pipelines,
with data types covering sequences and sequence anno-
tations from GenBank (http://www.ncbi.nlm.nih.gov/
genbank/) and UniProt (http://www.uniprot.org), im-
mune epitopes from the Immune Epitope Database
(IEDB; http://www.iedb.org), 3D protein structures
*To whom correspondence should be addressed. Tel: +1 858 200 1876; Fax: +1 858 200 1880; Email: rscheuermann@jcvi.org
C© The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Nucleic Acids Research, 2017, Vol. 45, Database issue D467
from the Protein Data Bank (PDB; http://www.rcsb.
org/pdb), clinical, surveillance and host factor data (2)
from direct submissions and curated antiviral drug data
from DrugBank (http://www.drugbank.ca);
ii) a growing suite of analytical and visualization tools
customized for influenza virus data analysis, including
tools formultiple sequence alignment, phylogenetic tree
reconstruction in high performance computing envi-
ronments, sequence variation determination, metadata-
drivenComparativeAnalysis Tool for Sequences (meta-
CATS) (3), BLAST comparison, short peptide identi-
fication, PCR primer design, genome sequence anno-
tation, Sequence Feature (4) and Phenotypic Variant
Type (PVT) annotation, HA clade classification, HA
subtype numbering conversion, surveillance data visu-
alization, protein structure visualization and host factor
data enrichment analysis; and
iii) personal workbench spaces for data storage and shar-
ing.
The growing importance of IRD for influenza research is
evidenced by its steadily increasing usage. The number of
scholarly articles citing IRD totaled 430 as of August 10,
2016, among which almost half appeared in the last three
years and about 20% published in the last 12 months. Fur-
thermore, Influenza and Other Respiratory Viruses also re-
ported that the IRD database paper (5) was the #1 cited
paper in the journal in 2014. In a survey of research ar-
ticles that were published in 2011 and had received NIH
funding, IRD was the 6th most frequently acknowledged
repository for molecular data, behind only some of the ma-
jor databases managed by the U.S. National Library of
Medicine (6). In addition, the IRD website has been heav-
ily used by researchers worldwide, with over 1300 usage ses-
sions per week on average in 2015 as per Google Analytics.
Since its initial launch, the IRD team has continued to
improve the resource by adding new features and new data.
In this article we highlight the major improvements in IRD
since the last publication about IRD in 2012 (5).
NEW SYSTEM ENVIRONMENTS
Cloud environment
The IRD user community has been growing continuously.
In order to provide faster and more reliable services to the
many concurrent users, the IRD infrastructure migrated
to the Amazon Web Services (AWS) cloud in July 2016.
Through this new cloud environment, we expect to provide
higher performance and more stable services to IRD users.
Our initial performance test showed that the IRD resource
hosted in AWS was ∼2X faster for general database query
tasks and ∼6X faster for more complex analyses.
High performance computing environment
Increased influenza virus surveillance and sequencing ef-
forts worldwide resulted in an increasingly large number of
influenza virus sequences and related data, calling for com-
putational infrastructures that can support large-scale data
storage and analysis. To meet the needs of computation-
ally intensive analyses, IRD has partnered with the NSF-
sponsoredCyber-Infrastructure for Phylogenetic RESearch
(CIPRES) Gateway (7) and now provides users with an op-
tion to perform computationally-intensive tasks in a high
performance computing environment. Specifically, when a
user submits a large phylogenetic analysis job to IRD, the
user is provided with the option of running the analysis in
the CIPRES environment. If the user chooses this option,
the sequences needed to generate a tree are sent to CIPRES
through an application programming interface (8). Tree cal-
culations are performed in the high performance computing
environment, and the resulting tree file is then returned for
visualization in the Archaeopteryx tree viewer in IRD (9).
An important advantage of the Archaeopteryx implemen-
tation in IRD is that it supports user-drivenmetadata-based
tree leaf coloring, which allows for visual pattern recogni-
tion in the phylogenetic data. This collaboration between
scientific resources allows users to leverage both the high
performance computing environment in CIPRES and the
metadata-based tree decoration options in IRD.
NEW FEATURES
Custom metadata capturing utility
As previously mentioned, one unique capability of IRD is
the customized tree viewer, allowing users to color code tree
nodes based on sequence-associated metadata, including
geographic location, host species, year and season of isola-
tion, HA and NA subtype, H5 clade membership and spe-
cific amino acids present at selected protein positions. Pre-
viously, this function was only available for trees generated
solely from IRD sequences. As this feature became popu-
lar, users requested to be able to decorate trees that include
their own custom sequences in a similar way. These requests
drove the development of a new utility for capturing user-
provided metadata. With this new tool, users can provide
sequence-associated metadata either in the header of the
FASTA sequence file or in a separate metadata spreadsheet.
User-provided sequence data and metadata can be further
combined with IRD data if desired and then analyzed us-
ing any IRD tools. In the case of phylogenetic tree analy-
sis, users can now visualize and decorate a tree based on
custom metadata values in the Archaeopteryx tree viewer
(Figure 1). Likewise, this new utility allows users to au-
tomatically separate sequences by user-provided metadata
values for downstream comparison of sequence groups us-
ing meta-CATS (3).
Influenza virus variant protein annotations
In recent years, the influenza community has identified sev-
eral novel proteins generated from non-canonical transla-
tion strategies such as leaky ribosomal scanning (PB1-F2
(10), PB1-N40 (11), PA-N155 (12) and PA-N182 (12)), ribo-
somal frameshift (PA-X (13)) and alternative splicing (M42
(14) and NS3 (15)). Anticipating the desire to search and
analyze these newly discovered variant proteins, the IRD
team developed a custom annotation algorithm that pre-
dicts the open reading frames and protein sequences for
each of the PB1-N40, PA-N155, PA-N182, PA-X, M42 and
NS3 variant proteins. Using this algorithm, the IRD team
has annotated all relevant influenza segment sequences with
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Figure 1. A phylogenetic tree constructed from a combination of user-provided sequences (downloaded fromGISAID) and IRD sequences, and visualized
in the IRD tree viewer. Tree leaves are color-coded by subtype. The green brace indicates user-provided sequences colored by user-provided HA and NA
subtype metadata.
variant proteins if they are predicted to be present. These
predicted sequences can be retrieved from the Nucleotide
Sequence Search and Protein Sequence Search pages (Fig-
ure 2A), transferred to any IRD analysis tools (Figure
2B) and downloaded. As of July 2016, over 92% of com-
plete genome strains in IRD have predicted PB1-N40, PA-
N155, PA-N182 and PA-X (in three variant forms: +41,
+61 or other) proteins (Table 1). M42 and NS3 have very
rare and strict alternative splicing, and are therefore only
found in 0.2% and 0.1% of influenza strains, respectively.
Intriguingly, M42 is predicted to be found in mainly lab-
oratory passaged strains including A/WSN/1933(H1N1)
and A/Puerto Rico/8/1934(H1N1), strains from the 1934
highly pathogenic avian influenza Germany outbreak, the
1968 Hong Kong H3N2 outbreak, the 1976 and 1983–1984
NorthAmerican swine flu outbreaks, the 1986NorthAmer-
ican avianH5N2 outbreak, as well as several vaccine strains.
Phenotype markers and predicted phenotypic effects
In the early stage of IRD development, we developed a
novel component for studying genotype-phenotype associ-
ations – the Sequence Feature Variant Type (SFVT) com-
ponent (4). To develop this component, the IRD team com-
piled a knowledgebase of influenza virus Sequence Features
(SFs), where SFs are defined as protein regions with specific
interesting structural or functional characteristics. For each
SF, all protein sequences in IRD are grouped into individ-
ual Variant Types, which are defined by the unique sequence
variations existing within the defined SF region. More re-
cently, the SFVT component has been extended to highlight
Variant Types that are known to be associated with impor-
tant phenotypic characteristics.
In response to the highly pathogenic avian influenza
H5N1 outbreaks, especially considering the expansion of
host and geographic ranges, the WHO Collaborating Cen-
ter for Influenza Reference and Research and the US Cen-
ters for Disease Control and Prevention (CDC) compiled
an H5N1 Genetic Changes Inventory (16) to help iden-
tify H5N1 strains of concern to cause a potential pan-
demic. This inventory includes 150 experimentally deter-
mined sequence markers associated with a wide range
of phenotypic functions: determinant of virulence, tissue
tropism, clinical symptoms of disease, replication efficiency,
polymerase activity, activation pH, transmissibility, species
adaptation, antiviral drug activity, temperature sensitivity,
affecting type I IFN pathway and inflammatory response.
In order to assist in improving early detection of high-risk
H5N1 viruses, we have added these phenotype-associated
sequence markers into the SFVT component of IRD. Ev-
ery relevant protein sequence in IRD has been annotated
with these SFs and whether the sequence carries a particu-
lar Phenotypic Variant Type (PVT) that is predicted to give
rise to a phenotypic consequence (Figure 3A and B). Over-
all, approximately 66% of influenza strains in IRD contain
at least one PVT.
One application of the PVT annotations is to provide
guidance for surveillance. In particular, certain PVTs could
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Figure 2. Variant protein annotations in Influenza Research Database (IRD). (A) The IRD Protein Sequence Search page supports queries based on
‘classical proteins’, ‘variant proteins’ and sequence-associated metadata. (B) A portion of the Protein Sequence Search Results page from a query of PA-X,
showing annotations of three PA-X variants: PA-X (+41), PA-X (+61) and PA-X (other). Selected records from this page can be input to any of the analysis
tools under the ‘Run Analysis’ dropdown menu (red arrow), or downloaded to a local computer.
Table 1. Variant protein annotations in IRD
Variant Protein Variant Protein from Complete Genomes Percentage Source
PB1-F2 19 701 69.8% GenBank
PB1-N40 27 909 98.9% IRD
PA-N155 28 086 99.3% IRD
PA-N182 26 099 92.2% IRD
PA-X 27 996 98.9% IRD
PA-X protein(+41) 8199 29.0% GenBank & IRD
PA-X protein(+61) 19 721 69.7% GenBank & IRD
PA-X protein(other) 76 0.3% GenBank & IRD
PA-X protein 2834 10.0% GenBank
M42 69 0.2% IRD
NS3 30 0.1% IRD
be used as risk markers for selecting isolates that warrant
further investigation. As an example, the PVT of Influenza
A PB2 determinant-of-virulence 591(1) 591K increased-
virulence, which confers increased virulence, is found in
88 strains, mostly from avian strains of H1N1, H3N2 or
H9N2 subtypes. However, it has also been found in eight
human strains, including subtypes that have caused severe
disease in humans such as H7N9 and H5N1 (Figure 3C).
Although this PVT is only currently found in less than 1%
of strains in IRD, it is important to maintain surveillance
of this PVT in the population given its association with
disease severity, especially during a pandemic outbreak.
Users can also predict the phenotypic effects of their own
sequences by using the SF-PVT annotation tool accessible
from the Identify Sequence Features in Segments page.
Moreover, the SF-PVT annotations have been fully in-
tegrated with other IRD sequence analysis tools, including
the Sequence Variation Analysis and meta-CATS (3) tools.
This integration helps users to predict whether a mutation
found in an analysis is likely to result in a phenotypic effect.
Hemagglutinin (HA) clade classifications
IRD development is frequently driven by suggestions from
the user community. The United States Department of
Agriculture (USDA) Influenza A Virus in Swine Surveil-
lance Program (17) routinely identifies and sequences in-
fluenza viruses from the domestic swine population and re-
quested an automated tool that could classify sequences
into phylogenetic clades. In collaboration with swine in-
fluenza experts at the USDA, the IRD team developed an
algorithm to classify the phylogenetic lineages (18) of all
North American swine HA (H1) sequences in the IRD
database. This algorithm constructs an HA reference tree
and then applies the pplacer method (19) to place the query
sequence into the reference tree, thus identifying the most
closely related lineage of the query sequence. All relevant
swine H1 sequences in IRD have now been assigned a clade
annotation using this approach. In North America, the
most prevalent swineH1 clade is gamma (34.33%), followed
by delta1 (24.57%) and beta (13.56%) (Supplementary Ta-
ble S1). Such clade annotations are searchable via a dedi-
cated Swine H1 Clade Sequence Search page. This classifi-
cation tool is also available for predicting the H1 clade for
user-provided sequences.
A related tool in IRD is anH5N1 clade classification tool.
Since 2008, H5N1 viruses in the highly pathogenic avian in-
fluenza (HPAI) A/goose/Guangdong/1/1996-lineage have
been continuously circulating in isolated geographical re-
gions. To help monitor the evolution of H5N1 virus for
its epizootic and pandemic potential, the IRD team devel-
oped the H5N1 clade classification tool, which classifies the
clade of both highly pathogenic and low pathogenic H5HA
sequences. Similar to the H1 clade classification tool, this
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Figure 3. Phenotypic Variant Type (PVT) annotation in IRD. (A) A portion of the Strain Details page for A/Nanjing/1/2013 (H7N9) shows that
this human isolate carries the PVTs Influenza A PB2 determinant-of-virulence 591(1) 591K increased-virulence, which confers increased virulence,
and Influenza A PB2 tissue-tropism 701(1) 701D Systemic-infection, which confers systemic infection in mouse models, but does not carry Influenza
A PB2 polymerase-activity 28(5) 28I, 274T, 526R, 553V, 607V Decreased-polymerase-activity, which confers reduced polymerase activity. (B) The Se-
quence Feature Details page for the Influenza A PB2 determinant-of-virulence 591(1) 591K increased-virulence showing the SF metadata and variant
type (VT) calculation. Within the IRD database, 88 strains, including 8 human strains, carry this PVT (VT-4). The strain count column links to all strains
harboring the corresponding VT. (C) Host and subtype distribution of VT-4 from panel B.
algorithm uses phylogenetic analysis to place H5 HA se-
quences within the WHO classification scheme (20).
All IRD H5 sequences, regardless of host, have been an-
notated with an H5 clade designation. Most H5 sequences
are from Asia, comprising 64% of H5 sequences in IRD
and from all documented clades in the H5 phylogenetic tree
(Supplementary Table S2). In contrast, H5 sequences from
other continents are restricted to certain lineages. For ex-
ample, in North American, 89% of H5s fall into the Amer-
ican non-Goose Guangdong lineage, while all HPAI H5s
(9%) are from the 2014–2015 avian outbreak and classi-
fied into clade 2.3.4.4 (highlighted in red). For comparison,
most African and European H5s belong to clade 2.2 and its
derived lineages, accounting for 91% and 61% of the total
H5s, respectively. This suggests that among all HPAI H5s
originating in Asia, only certain lineages have migrated to
other continents. The H5 annotations can be searched via
a tailored H5N1 Clade Sequence Search page. In addition,
users can also annotate their own H5 sequences using the
H5N1 Clade Classification Tool in IRD.
HA subtype numbering conversion
There is increased interest in comparing amino acid substi-
tutions across different HA subtypes in order to perform
analyses such as comparing amino acids involved in gly-
can binding by different HA subtypes, comparing substi-
tutions at positions that are associated with other pheno-
typic and functional changes, and identifying broad range
cross-reactive immune epitopes. However, comparing spe-
cific residues between different subtypes using sequence-
based alignments alone has been challenging. Recently
Burke and Smith (21) proposed a cross-subtype HA num-
bering scheme for the 18 influenza A and influenza B sub-
types, using a combination of HA sequence and struc-
tural data to propose positions of functional equivalence
across the different subtypes. IRD implemented the HA
Subtype Numbering Conversion Tool based on this num-
bering scheme. This tool allows users to convert the coor-
dinates of any HA protein sequence to the corresponding
coordinates in any other subtypes. This subtype numbering
conversion tool is also integrated with other analysis tools
in IRD, including Sequence Variation Analysis and meta-
CATS (3), for converting the coordinates of an analysis re-
sult into a different coordinate system.
As an example use of this tool, we explored sequence
conservation of H1 B-cell epitopes across all HA subtypes.
This analysis involved the following four steps: (i) Firstly,
we searched for H1 HA B-cell epitopes using the Sequence
Feature Variant Type Search page in IRD. In July 2016, this
query returned 90 epitope records. (ii) Secondly, we con-
Nucleic Acids Research, 2017, Vol. 45, Database issue D471
verted the H1 numbering into that for all the other HA
subtypes. This was done by inputting the H1 reference se-
quence into the HA Subtype Numbering Conversion tool
in IRD, and then selecting all subtypes in the Conversion
Sequence Numbering Scheme list. This tool BLASTs the
input sequence against all HA reference sequences, returns
the closest reference sequence (22) and then converts the in-
put numbering into that for other subtypes. The HA Sub-
type Numbering Conversion Result page displays a coordi-
natemapping table as well as an alignment file for download
(Figure 4A). (iii) Thirdly, we used the coordinate mapping
table to map all H1 epitopes from step i to the reference
strain of other subtypes. (iv) Lastly, for each epitope, we
calculated the percent identity across the reference strains
representing all subtypes. This analysis found that H1 B-
cell epitopes in the HA stem are highly conserved across all
subtypes; epitopes in the HA head are more variable in gen-
eral, however, several epitopes in the head region are also
conserved across all subtypes (Figure 4B). These conserved
epitopes are candidate targets for eliciting a cross-reactive
immune response.
NEW DATA TYPES
Linkouts to disease event data
To study virus evolution in the context of virus outbreaks,
it is critical to have both epidemiological and genetic data.
Since its inception, IRD has served as the repository for
avian influenza virus surveillance data collected by the Cen-
ters of Excellence for Influenza Research and Surveillance
(CEIRS) program. Concurrently, the Food and Agriculture
Organization (FAO) of the United Nations receives data on
worldwide animal disease events and provides access to such
data through the Global Animal Disease Information Sys-
tem - EMPRES-i (23). In collaborationwith EMPRES-i de-
velopers, IRD has now established links between strain and
sequence records in IRD and disease event information in
EMPRES-i. Such integration of surveillance and sequence
data facilitates research on the evolution andmolecular epi-
demiology of influenza viruses.
Host factor data
Avariety of different cellular proteins are utilized by viruses
to facilitate viral replication. Conversely, other host fac-
tors function to sense the presence of viruses and prevent
their further replication. There has been a growing inter-
est in applying systems biology approaches to explore host-
virus interactions to better understand the host responses
to virus infections. Initially developed as a resource focused
on virus data, IRD has expanded its scope to capture host
factor data produced by the NIAID Systems Biology for
Infectious Diseases Research program (2). As of July 2016,
IRD provides access to 57 structured data sets regarding
host responses to virus infection, among which 35 are re-
lated to influenza virus infection experiments. Currently
supported experiment types include transcriptomic, pro-
teomic and lipidomic experiments. The uniqueness of the
IRD host factor component lies in: (i) providing standard-
ized experiment and sample metadata, (ii) displaying tran-
scriptional response patterns computed from an in-house
statistical pipeline, (iii) enabling the comparison of host re-
sponses detected under different experimental and infection
conditions, and (iv) supporting gene set enrichment analy-
sis.
To illustrate the functionality of the host factor compo-
nent, we explored the host response patterns to H5N1 virus
infection followed by gene enrichment analysis using the fol-
lowing workflow: (i) To begin, we searched for host factor
experiments using VN1203 (H5N1) as the viral agent. As
of July 2016, this query returned 11 experiments, including
seven transcriptomic and four proteomic experiments (Fig-
ure 5A). (ii) From the returned experiment list, we selected
experiment ‘ICL004-R’ to load the Experiment Details
page. This page displays experiment information, an exper-
iment sample summary, host factor bioset information, a
host factor bioset summary, host factor bioset patterns and
host factor results. Each bioset contains a list of host fac-
tors generated from a statistical comparison between virus
infected and mock-infected samples. (iii) The Host Fac-
tor Bioset Patterns section of the Experiment Details page
shows statistically-significant host factors grouped by ex-
pression patterns. For this use case, we searched for the ex-
pression pattern of interferon beta gene in this experiment
by entering ‘IFNb’ into the Symbol search box and select-
ing ‘Find’. The expression pattern for IFNb was found to
be ‘0,0,+,+,+,+’ (Figure 5B), indicating that transcription
of IFNb was significantly upregulated during the latter 4
timepoints of the experiment. (iv) Next, we selected the hy-
perlinked host factor number to retrieve all host factors ex-
hibiting the same expression pattern, together with the asso-
ciated fold change and statistical support values. This host
factor list can be saved to a working set in the workbench,
downloaded to local computers, or transferred to pathway
analysis tools. (v) In order to perform pathway enrichment
analysis, we selected all host factors by ticking the ‘Select
all’ box above the table, mousing over the ‘Run Analysis’
dropdown menu and selecting ‘Enrichment Analysis’. On
the Enrichment Algorithm and Gene-Annotation Collec-
tion page, we selected Enrichment Algorithm––CLASSIFI,
Gene-Annotation Collection––Gene Ontology (GO) and
Gene-Annotation Background––From Experiment. The
Enrichment Analysis Result page then gave the GO terms
and associated P-values calculated by the CLASSIFI algo-
rithm using a hypergeometric distribution function (Figure
5C) (24). One of the most significant biological processes
enriched in this gene set is ‘cellular response to type I in-
terferon’ as might be expected from an expression pattern
that includes interferon beta. This workflow demonstrates
the power of the host factor component and how it can be
applied to better understand the host response to viral in-
fection.
Antiviral drug data
As IRD continues to grow and expand, a new focus area
is to develop a comprehensive support infrastructure for
antiviral drug data management and analysis. Most re-
cently, the IRD development team has curated antiviral
drug data related to influenza virus as well as other viruses
supported in the Virus Pathogen Resource (www.viprbrc.
org) (25), a sister resource of IRD. Current antiviral drug
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Figure 4. HA subtype numbering conversion in IRD. (A) The HA Subtype Numbering Conversion Result page showing the sequence alignment and
mapping table for a query H1 sequence mapped into coordinate space for other HA subtypes. The mapping table was used to map all H1 B cell epitopes to
all other subtypes. (B) A schematic view of all experimentally determined H1 B cell epitopes in the HA protein. Epitopes are colored based on the average
percent amino acid identity cross all HA subtypes.
A B
C
Figure 5. Host factor component in IRD. (A) A portion of the Host Factor Experiments page, showing a list of experiments using A/Vietnam/1203/2004
human isolate (VN1203 (H5N1)) as the viral agent. (B) The Host Factor Bioset Patterns table showing the expression pattern of IFNb in this experiment.
(C) A portion of the Enrichment Analysis Result page displaying the terms, the collections (GO categories in this case) and the P-values calculated by the
CLASSIFI algorithm using a hypergeometric distribution function.
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data includes descriptive drug information, 3D structures
for drug/protein target complexes, specific drug interaction
sites and antiviral resistance mutations.
USER SUPPORT
To help the community utilize the wide range of functional-
ities provided in the resource, IRD provides on-site training
workshops, demonstration workshops in conjunction with
major scientific meetings, as well as online tutorials and
trainingmaterials. In the past five years, IRD has sponsored
on-site training workshops at 22 institutes including the
NIH,USCDC,USDA,HarvardUniversity,Massachusetts
Institute of Technology, Chinese CDC, Chinese Academy
of Sciences and Duke-NUS Graduate Medical School of
Singapore, reaching approximately 600 users with hands-on
training. Additionally, a Contact Us form is provided on
the website to assist users with specific questions. Finally,
all IRD protocols are described in SOPs on the website for
users interested in the underlying computational details.
FUTURE DEVELOPMENTS
Building upon the curated anti-viral drug data, IRD is in
the process of expanding the antiviral drug component by:
(i) curating drug interaction sites as Sequence Features and
subsequently predicting whether a virus strain is likely to
be drug resistant using our existing PVT computational
pipeline, (ii) integrating host factor data with drug target
data to facilitate the discovery of potential host factor drug
targets, (iii) representing drug target data using the Open-
BEL language and (iv) developing an anti-viral drug resis-
tance risk assessment tool.
In the initial implementation, IRD integrated several
Java-applets for various analysis and visualization tasks.
With support for Java being phased out of some web
browsers, these applets are being replaced by JavaScript al-
ternatives. Recently IRD has implemented the JSMOL pro-
tein structure viewer as an alternative to JMOL. Replace-
ments for the JalView sequence alignment viewer and Ar-
chaeopteryx tree viewer are currently under development.
As new variant proteins are identified by the influenza re-
search community and reported in the scientific literature
(26), the IRD team evaluates the strength of evidence for
the presence and importance of these novel proteins, deter-
mines the sequence signals that can be used to predict their
expression, and adds the specific prediction algorithm to
our variant protein prediction infrastructure, making these
sequence annotations uniquely available in IRD for user
query and downstream analysis.
By continuing to expand data contents and analysis func-
tionalities, IRD continues to provide a powerful bioinfor-
matics resource for influenza virus data mining and hypoth-
esis generation, thus expediting the research and develop-
ment of diagnostics, vaccines and therapeutics against in-
fluenza virus.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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